US Map / Utah
State UT

Clinical Trials in Utah

Utah is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Utah and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 187 actively recruiting studies with Utah sites out of 187 registered in total. The busiest research areas in Utah are Multiple Myeloma, Heart Failure, Non-small Cell Lung Cancer. Leading sponsors running trials in the state include University of Utah, AstraZeneca, National Cancer Institute (NCI). By stage, Utah trials break down as Phase 1 (41), Phase 2 (58), Phase 3 (49), Phase 4 (2).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
187
Recruiting Now
187
← Back to US Map
Top Conditions in Utah
Multiple Myeloma (4)Heart Failure (4)Non-small Cell Lung Cancer (3)Ulcerative Colitis (3)Breast Cancer (3)Stroke (3)Prostate Cancer (3)Acute Myeloid Leukemia (2)Hidradenitis Suppurativa (HS) (2)Neuroblastoma (2)Non-Small Cell Lung Cancer (2)Ovarian Cancer (2)

Frequently Asked Questions — Clinical Trials in Utah

How many clinical trials are currently recruiting in Utah?
ClinicalMetric currently tracks 187 actively recruiting clinical trials with at least one location in Utah. The total number of registered studies—including active but not currently enrolling trials—is 187. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Utah?
Utah hosts clinical trials across a broad range of medical conditions, including Multiple Myeloma, Heart Failure, Non-small Cell Lung Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Utah serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Utah?
To join a clinical trial in Utah, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Utah maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Utah

NCT07221357 Phase 2, Phase 3
Recruiting
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Che...
Condition
Untreated, Unresectable, or Metastatic Colorectal Cancer
Enrollment
990 pts
Location
United States, Argentina, Australia
Sponsor
Bristol-Myers Squibb
View Trial →
NCT04640584 N/A
Recruiting
C-Brace Prospective Registry
Condition
Pareses
Enrollment
250 pts
Location
United States, Australia, Germany
Sponsor
Otto Bock Healthcare Products
View Trial →
NCT04065399 Phase 1, Phase 2
Recruiting
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rea...
Condition
Acute Myeloid Leukemia
Enrollment
447 pts
Location
United States, Australia, Canada
Sponsor
Syndax Pharmaceuticals
View Trial →
NCT07766005 Phase 2
Recruiting
A Study of SPY072 in Adults With Moderate to Severe Hidradenitis Suppurativa (Th...
Condition
Hidradenitis Suppurativa (HS)
Enrollment
150 pts
Location
United States, Canada
Sponsor
Spyre Therapeutics, Inc.
View Trial →
NCT05552222 Phase 3
Recruiting
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR)...
Condition
Multiple Myeloma
Enrollment
1,590 pts
Location
United States, Australia, Austria
Sponsor
Janssen Research & Development
View Trial →
NCT07648953 N/A
Recruiting
Microvideos for Improving HPV Vaccination Among Childhood Cancer Survivors
Condition
HPV Vaccination
Enrollment
55 pts
Location
United States
Sponsor
University of Utah
View Trial →
NCT02744677 N/A
Recruiting
COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients...
Condition
Complex Congenital Heart Defect
Enrollment
108 pts
Location
United States
Sponsor
Edwards Lifesciences
View Trial →
NCT06307665 Phase 3
Recruiting
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As ...
Condition
Asthma
Enrollment
440 pts
Location
United States, China, Mexico
Sponsor
AstraZeneca
View Trial →
NCT07175428 Phase 2
Recruiting
Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Antic...
Condition
Atrial Fibrillation (AF)
Enrollment
1,200 pts
Location
United States, Argentina, Brazil
Sponsor
Regeneron Pharmaceuticals
View Trial →
NCT06127199 N/A
Recruiting
Contraceptive Efficacy Study of Ovaprene
Condition
Contraception
Enrollment
656 pts
Location
United States
Sponsor
Daré Bioscience, Inc.
View Trial →
NCT07584434 Phase 1
Recruiting
A Phase 1, First-in-human Study of VX-433
Condition
Narcolepsy Type 1 (NT1)
Enrollment
118 pts
Location
United States
Sponsor
Vertex Pharmaceuticals Incorpo
View Trial →
NCT05135975 Phase 2
Recruiting
A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurre...
Condition
Neuroblastoma
Enrollment
86 pts
Location
United States
Sponsor
Nationwide Children's Hospital
View Trial →
NCT05765812 Phase 1, Phase 2
Recruiting
A Study of Zedoresertib (Debio 0123) in Combination With Temozolomide in Adult P...
Condition
Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype
Enrollment
116 pts
Location
United States, Spain, Switzerland
Sponsor
Debiopharm International SA
View Trial →
NCT07002034 Phase 2
Recruiting
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medic...
Condition
Adjustment Disorder
Enrollment
100 pts
Location
United States
Sponsor
Reunion Neuroscience Inc
View Trial →
NCT01401998 N/A
Recruiting
ARPKD Database Study
Condition
Hepato/Renal Fibrocystic Disease
Enrollment
200 pts
Location
United States
Sponsor
Children's Hospital of Philade
View Trial →
NCT06121011 N/A
Recruiting
A Global Prospective Observational Registry of Patients With Pompe Disease
Condition
Pompe Disease
Enrollment
500 pts
Location
United States, Austria, Belgium
Sponsor
Amicus Therapeutics
View Trial →
NCT07479498 N/A
Recruiting
Mountain West Prevention Research Center Core Research Project
Condition
Childhood Obesity
Enrollment
600 pts
Location
United States
Sponsor
Paul Estabrooks
View Trial →
NCT06087029 N/A
Recruiting
IMPRoving Outcomes in Vascular DisEase - Aortic Dissection
Condition
Type B Aortic Dissection
Enrollment
1,100 pts
Location
United States, Canada
Sponsor
Duke University
View Trial →
NCT07061951 Phase 2
Recruiting
Testing the Effectiveness of the Anti-cancer Drug, Mirdametinib, in Treating Rel...
Condition
Recurrent Chronic Lymphocytic Leukemia
Enrollment
20 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
NCT05446272 N/A
Recruiting
The Diaphragmatic Initiated Ventilatory Assist (DIVA) Trial
Condition
Extubation Failure
Enrollment
478 pts
Location
United States, Canada
Sponsor
University of Pennsylvania
View Trial →
NCT04683653 Phase 1, Phase 2
Recruiting
Study of Pelvic Hypofractionated Radiotherapy in Endometrial Cancer
Condition
Endometrial Cancer
Enrollment
100 pts
Location
United States
Sponsor
University of Chicago
View Trial →
NCT07276373 Phase 1, Phase 2
Recruiting
Two Part Study of Nenocorilant Combined With Nivolumab in Patients With Advanced...
Condition
Neoplasms
Enrollment
50 pts
Location
United States
Sponsor
Corcept Therapeutics
View Trial →
NCT04752722 Phase 1, Phase 2
Recruiting
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incom...
Condition
Superficial Bladder Cancer
Enrollment
350 pts
Location
United States, Australia, Canada
Sponsor
enGene, Inc.
View Trial →
NCT07369089 Phase 2
Recruiting
Targeting Treatment-Resistant OUD With Ketamine-Assisted Mindfulness Oriented Re...
Condition
Opioid Use Disorder
Enrollment
88 pts
Location
United States
Sponsor
University of California, San
View Trial →
NCT07361562 Phase 1
Recruiting
A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Soli...
Condition
Advanced Solid Tumor, Adult
Enrollment
100 pts
Location
United States
Sponsor
Cogent Biosciences, Inc.
View Trial →
Page 1 of 8 — 187 trials total
Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology